Dr. Clay Siegall and Cancer Research

Since its founding in 1998, Seattle Genetics has been working hard with human antibodies. The company has been studying, manipulating, and packaging drugs in hopes of creating a toxic therapy, something that will destroy a cancer cell from the inside out. This strategy, if successful, could put Seattle Genetics in the pharmaceutical “big league.” Seattle […]